Nature Biotechnology 2000 Emma Dorey - Abstracts
| Nature Biotechnology 2000 Emma Dorey | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Chiral drugs viable, despite failure.(Analysis) | Business | Emma Dorey | |||
| G-8 leaders fudge biotech position. | Business | Emma Dorey | |||
| IPOs, follow-ons, proceed. | Business | Emma Dorey | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.